Search for: "Teva Pharmaceuticals" Results 941 - 960 of 1,429
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 May 2011, 7:52 am by Tron Emptage
  Generic Opioid Products Generic Name Drug Name Applicant/Sponsors Fentanyl Fentanyl Extended Release Transdermal System Actavis   Fentanyl Fentanyl Extended Release Transdermal System Lavipharm Labs   Fentanyl Fentanyl Extended Release Transdermal System Mylan Technologies   Fentanyl Fentanyl Extended Release Transdermal System Teva Pharms   Fentanyl Fentanyl Extended Release Transdermal System Watson   … [read post]
2 May 2011, 4:28 am by By CHRIS V. NICHOLSON
The deal for the biopharmaceutical company comes just weeks after Cephalon rejected a $5.7 billion takeover bid from Valeant Pharmaceuticals. [read post]
24 Apr 2011, 9:30 pm by Patent Docs
District Court for the Eastern District of Texas against Par and the generic drugmakers Alphapharm, Teva, and Dr. [read post]
23 Apr 2011, 9:58 pm
German pharmaceutical giant Bayer, which manufactures Yasmin and YAZ, in a statement, said that the side effects were "an uncommon event" and noted that pregnancy would increase the deadly risks even more. [read post]
21 Apr 2011, 1:36 pm by Bexis
Teva Pharmaceuticals USA, Inc., 2007 WL 5787186 (S.D. [read post]
19 Apr 2011, 5:04 pm by Marie Louise
Teva and ratiopharm (EPLAW) Fentanyl – Germany: Federal Court of Justice: Lessons to be learned for claim construction and novelty: Xa ZR 149/07 (Kluwer Patent Blog) Finasteride – France: Tribunale de Grande Instance de Paris: Murder me twice – Merck’s dosage regime patent held invalid again: Teva v Merck Sharp & Dohme (EPLAW) Gaviscon (Sodium alginate, Sodium bicarbonate, Calcium carbonate) – UK: Reckitt Benckiser fined £10.2 M for halting… [read post]
18 Apr 2011, 2:13 pm by Ronald V. Miller, Jr.
The FDA warned consumers about the generic acid reflux drug Lansoprazole made by Teva Pharmaceutical Industries when the drug is administered by oral syringe or feeding tube. [read post]
12 Apr 2011, 10:07 pm by Marie Louise
Highlights this week included: Cosopt (Dorzolamide, Timolol) – UK: EWCA (Civ) rejects bid to revive patent covering Cosopt: Merck v Teva (IPKat) (The IP Factor) (EPLAW) (GenericsWeb) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
6 Apr 2011, 12:18 am by Marie Louise
Highlights this week included: India firm on ‘NO’ to data exclusivity (SiNApSE) (Generic Pharmaceuticals and IP) (Spicy IP) (Spicy IP) US: CAFC hears oral arguments on patentability of DNA claims: American Molecular Pathology, et. al, v. [read post]
5 Apr 2011, 2:35 pm by FDABlog HPM
  Par opposed the Motion to Dismiss arguing that pursuant to the Federal Circuit’s decision in Teva Pharmaceuticals USA, Inc. v. [read post]
29 Mar 2011, 9:19 pm by Marie Louise
General Pharmaceutical, biotechnology and chemical inventions – world protection and exploitation (FDA Law Blog) Gene patents on the high seas: who owns the ocean’s IP? [read post]
28 Mar 2011, 7:32 am by Adam Schlossman
”Certiorari stage documents:Opinion below (3d Circuit)Petition for certiorariBrief in oppositionPetitioners' replyAmicus brief of TEVA Pharmaceuticals USA, Inc.Amicus brief of Consumer Federation of America et al.Amicus brief of Mylan Pharmaceuticals, Inc.Amicus brief of Apotex, Inc.Amicus Generic Pharmaceutical AssociationCVSG Information:Invited: March 28, 2011 The Court rejected all attempts by Georgia death row prisoner Troy Davis to further pursue… [read post]
24 Mar 2011, 3:40 pm by Brian Baxter
.'s $409 million purchase of Drugstore.com, while Jones Day and Willkie Farr have roles on a joint venture under which Procter & Gamble and Teva Pharmaceuticals will market over-the-counter medicines. [read post]
24 Mar 2011, 12:53 pm by Christa Culver
”Certiorari stage documents:Opinion below (3d Circuit)Petition for certiorariBrief in oppositionPetitioners' replyAmicus brief of TEVA Pharmaceuticals USA, Inc.Amicus brief of Consumer Federation of America et al.Amicus brief of Mylan Pharmaceuticals, Inc.Amicus brief of Apotex, Inc.Amicus Generic Pharmaceutical Association Title: Stovall v. [read post]
22 Mar 2011, 4:21 pm by Marie Louise
General New IP resource for Pharma, Biotech and Chem – Compulsory licences, comparing national requirements (IP Think Tank) WIPO and India partner to protect traditional knowledge from misappropriation (WIPO) UN Rapporteur for the Right to Health asked to intervene in the TPP negotiation (KEI) Patents and doctors, and the USTR TPP text (KEI) Biotech industry losing interest in the therapeutic potential of RNAi (Patent Docs) India: The curious case of the ‘data exclusivity’ volte… [read post]
21 Mar 2011, 2:04 pm by Tom Lamb
And, thereafter, we will likely see: (1) Teva Pharmaceuticals and Barr Laboratories make an identical label change for Ocella, a generic version of Yasmin, as well as Gianvi, a generic version of YAZ; and, (2) Watson Pharmaceuticals do likewise for Zarah, another generic version of Yasmin. [read post]
16 Mar 2011, 3:50 am by Marie Louise
(EFF) US: Inter-agency group takes on counterfeit pharmaceuticals (PatentlyBIOtech) US: Recent Hatch-Waxman scholarship suggests patent settlement and product hopping create a ‘lethal combination’; another article proposes a ‘Smith Barney approach’ to 180-day exclusivity (FDA Law Blog) US: Sen Harkin urges FDA to avoid delays of generic drug approvals (GenericsWeb) Products Actos (Pioglitazone) – US: Takeda files patent infringement complaint against Apotex… [read post]
14 Mar 2011, 9:50 am by Dennis Crouch
Philips 74 14 Mag Instrument 70 15 Merck 69 16 3M Innovative Properties Company 67 17 Cygnus Telecommunications Technology 64 18 Schering 64 19 Millennium 63 20 Eli Lilly And Company 61 21 Promote Innovation (False Marking) 60 22 Melvino Technologies 59 23 Teva Pharmaceuticals 58 24 AstraZeneca AB 54 25 Eon-Net 54     Rank Patent Plaintiff Number of Defendants Non-Practicing Entity 1 Ronald A Katz Technology… [read post]